Atom Investors LP Crispr Therapeutics Ag Transaction History

Atom Investors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $983,760 - $1.26 Million	-24,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $1.99 Million - $2.7 Million	-56,051 Reduced 70.02%	24,000 $1.13 Million
Q1 2019 May 15, 2019	BUY	$28.02 - $40.87 $2.24 Million - $3.27 Million	80,051 New	80,051 $2.86 Million

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.